H.R. 1316 (112th): Stop Oxy Abuse Act of 2011

Introduced:
Apr 01, 2011 (112th Congress, 2011–2013)
Status:
Died (Referred to Committee)
Sponsor
Mary Bono Mack
Representative for California's 45th congressional district
Party
Republican
Text
Read Text »
Last Updated
Apr 01, 2011
Length
2 pages
Related Bills
H.R. 4956 (111th) was a previous version of this bill.

Referred to Committee
Last Action: Mar 25, 2010

 
Status

This bill was introduced on April 1, 2011, in a previous session of Congress, but was not enacted.

Progress
Introduced Apr 01, 2011
Referred to Committee Apr 01, 2011
 
Full Title

To direct the Commissioner of Food and Drugs to modify the approval of any drug containing controlled-release oxycodone hydrochloride to limit such approval to use for the relief of severe-only instead of moderate-to-severe pain, and for other purposes.

Summary

No summaries available.

Cosponsors
6 cosponsors (5R, 1D) (show)
Committees

House Energy and Commerce

Health

The committee chair determines whether a bill will move past the committee stage.

 
Primary Source

THOMAS.gov (The Library of Congress)

GovTrack gets most information from THOMAS, which is updated generally one day after events occur. Activity since the last update may not be reflected here. Data comes via the congress project.

Widget

Get a bill status widget for your website »

Citation

Click a format for a citation suggestion:

Notes

H.R. stands for House of Representatives bill.

A bill must be passed by both the House and Senate in identical form and then be signed by the president to become law.

The bill’s title was written by its sponsor.

GovTrack’s Bill Summary

We don’t have a summary available yet.

Library of Congress Summary

The summary below was written by the Congressional Research Service, which is a nonpartisan division of the Library of Congress.


4/1/2011--Introduced.
Stop Oxy Abuse Act of 2011 - Directs the Commissioner of Food and Drugs (FDA), within 90 days, to take such actions as may be necessary to modify the approval of, and limit any subsequent approval of, any drug containing controlled-release oxycodone hychloride to use for the relief of severe-only pain instead of moderate-to-severe pain.
Applies any such modification to drugs introduced into interstate commerce 180 days after enactment of this Act.

House Republican Conference Summary

The summary below was written by the House Republican Conference, which is the caucus of Republicans in the House of Representatives.


No summary available.

House Democratic Caucus Summary

The House Democratic Caucus does not provide summaries of bills.

So, yes, we display the House Republican Conference’s summaries when available even if we do not have a Democratic summary available. That’s because we feel it is better to give you as much information as possible, even if we cannot provide every viewpoint.

We’ll be looking for a source of summaries from the other side in the meanwhile.

Use the comment space below for discussion of the merits of H.R. 1316 (112th) with other GovTrack users.
Your comments are not read by Congressional staff.

comments powered by Disqus